Home » Topics » BioWorld Science

BioWorld Science
RSS

Bicycle Therapeutics expands collaboration with AstraZeneca

May 24, 2018

MIW-815 elicits strong and durable cancer immunity

May 24, 2018

Esperion's third pivotal study of bempedoic acid meets primary endpoint

May 24, 2018

DSMB recommends continuation of phase II study of Xanamem in Alzheimer's disease

May 24, 2018

Clinical results reported for bifunctional short-hairpin RNA for Ewing's sarcoma

May 24, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

FDA approves Yonsa for metastatic CRPC

May 24, 2018

PanOptica initiates phase I/II trial of PAN-90806 in wet AMD

May 24, 2018

Plant Advanced Technologies patents quinic acid derivatives

May 24, 2018

Center for Translational Drug Development synthesizes ROCK1/2 inhibitors

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...